Mirae Asset Global ETFs Holdings
ALXO icon

Mirae Asset Global ETFs Holdings’s ALX Oncology ALXO Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,771
Closed -$12.3K – 3012
2025
Q1 		$12.3K Buy
19,771
+858
+5% +$1.03K ﹤0.01% 3015
2024
Q4 		$31.6K Buy
18,913
+836
+5% +$1.28K ﹤0.01% 2962
2024
Q3 		$32.9K Buy
18,077
+5,061
+39% +$18.8K ﹤0.01% 2980
2024
Q2 		$78.5K Buy
+13,016
New +$160K ﹤0.01% 2663

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ALXO Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of ALX Oncology (ALXO) in Q2 2025, closing a stake of 19,771 shares — an estimated $12.3K sold.

Mirae Asset Global ETFs Holdings first reported a position in ALXO in Q2 2024 and held it in 4 quarters. The position peaked at $78.5K in Q2 2024. 61 funds tracked by Wall St. Rank hold ALXO as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining ALX Oncology position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 19,771 ALX Oncology shares in Q2 2025, an estimated $12.3K.
  • Mirae Asset Global ETFs Holdings first reported a position in ALX Oncology in Q2 2024 and held it in 4 quarters.
  • Mirae Asset Global ETFs Holdings's ALX Oncology position peaked at $78.5K in Q2 2024.
  • 61 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.